SJOGREN SYNDROME

Clinical trials for SJOGREN SYNDROME explained in plain language.

Never miss a new study

Get alerted when new SJOGREN SYNDROME trials appear

Sign up with your email to follow new studies for SJOGREN SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 3 Completed 4

New 'Off-the-Shelf' cell therapy trial targets six severe autoimmune diseases

Disease control Not yet recruiting

This early-stage study is testing a new cell therapy called BCT301 for people with severe autoimmune diseases that haven't responded to standard treatments. The therapy uses lab-made immune cells designed to target and remove harmful B cells, which are thought to drive these dise…

Matched conditions: SJOGREN SYNDROME

Phase: EARLY_PHASE1 • Sponsor: Peking University Third Hospital • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

SJOGREN SYNDROME

Get alerted when new SJOGREN SYNDROME trials appear

New 'Off-the-Shelf' cell therapy trial targets six severe autoimmune diseases